{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q15070",
      "entity_text" : "HSA",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "interpro:IPR001759",
      "entity_text" : "PTX",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Afterwards, PTX as a typical anticancer drug was added into the solution of 131 I-HSA at the mole ratio of 10:1 (PTX : HSA) to induce the self-assembly of HSA XREF_BIBR, forming 131 I-HSA-PTX nanoparticles.",
  "reading_complete" : "2020-08-03T17:01:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:59:54Z",
  "trigger" : "induce",
  "evidence" : [ "PTX as a typical anticancer drug was added into the solution of  131 I-HSA at the mole ratio of 10:1 (PTX: HSA) to induce the self-assembly of HSA" ],
  "pmc_id" : "5327637",
  "score" : 0
}